Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 100 participants.
Also called NCT07091682
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT07091682
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Germany, Hungary, Italy, Latvia, Poland, Spain, Switzerland
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT07091682. Allocation not applicable; no masking; primary purpose treatment. Start 2025-02-18 (actual); primary completion 2027-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions
- Acronym
- BIOMAG-LL
- Condition
- Coronary Artery Disease
- Condition
- Atherosclerosis of Coronary Artery
- Condition
- Myocardial Ischemia
- Condition
- Ischemic Heart Disease
- Condition
- Acute Coronary Syndromes
- Condition
- Angina Pectoris
- Intervention (Device)
- Implantation of a Sirolimus-Eluting Resorbable Coronary Magnesium Scaffold
- Lead sponsor
- Biotronik AG
Record details
- Record id
cardio:ct-nct07091682- Content hash
17198d5f16b1753cc02c616c33c7dd82de7193692106cbe002ba250777d183d1